These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 2286933)

  • 1. Studies on the interaction of daurisoline alkaloid derivatives and calmodulin by fluorescence spectroscopy.
    Sun Y; Hu ZY; Xu LM
    Second Messengers Phosphoproteins; 1990; 13(1):51-7. PubMed ID: 2286933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Daurisoline derivatives inhibit the ability of calmodulin to stimulate cyclic nucleotide phosphodiesterase activity.
    Hu ZY; Xu LM; Sun Y; Chen SL; Cai HM
    Cell Signal; 1990; 2(4):353-7. PubMed ID: 2252839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous binding of drugs with different chemical structures to Ca2+-calmodulin: crystallographic and spectroscopic studies.
    Vertessy BG; Harmat V; Böcskei Z; Náray-Szabó G; Orosz F; Ovádi J
    Biochemistry; 1998 Nov; 37(44):15300-10. PubMed ID: 9799490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydrophobic interaction of the Ca2+-calmodulin complex with calmodulin antagonists. Naphthalenesulfonamide derivatives.
    Tanaka T; Ohmura T; Hidaka H
    Mol Pharmacol; 1982 Sep; 22(2):403-7. PubMed ID: 7144734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Mg2+-binding sites and the role of Mg2+ on target recognition by calmodulin.
    Ohki S; Ikura M; Zhang M
    Biochemistry; 1997 Apr; 36(14):4309-16. PubMed ID: 9100027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of calmodulin by various metal cations as a function of ionic radius.
    Chao SH; Suzuki Y; Zysk JR; Cheung WY
    Mol Pharmacol; 1984 Jul; 26(1):75-82. PubMed ID: 6087119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of tamoxifen-like compounds on osteoclastic bone degradation, H(+)-ATPase activity, calmodulin-dependent cyclic nucleotide phosphodiesterase activity, and calmodulin binding.
    Williams JP; McDonald JM; McKenna MA; Jordan SE; Radding W; Blair HC
    J Cell Biochem; 1997 Sep; 66(3):358-69. PubMed ID: 9257192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies of the calmodulin-binding site of twitchin with synthetic peptides using fluorescence and CD spectroscopy.
    Buku A; Probst WC; Weiss KR; Heierhorst J
    Biochem Biophys Res Commun; 1996 Jan; 218(3):854-9. PubMed ID: 8579604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metofenazate as a more selective calmodulin inhibitor than trifluoperazine.
    Tkachuk VA; Baldenkov GN; Feoktistov IA; Men'shikov MY; Quast U; Herzig JW
    Arzneimittelforschung; 1987 Sep; 37(9):1013-7. PubMed ID: 2449225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Theoretical studies of the binding of trifluoperazine derivatives to site (82-93) of calmodulin: effect of lengthenings of the methylene linker chain on the binding affinity.
    Gresh N
    Mol Pharmacol; 1987 Jun; 31(6):617-22. PubMed ID: 3600606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium-dependent and -independent interactions of the calmodulin-binding domain of cyclic nucleotide phosphodiesterase with calmodulin.
    Yuan T; Walsh MP; Sutherland C; Fabian H; Vogel HJ
    Biochemistry; 1999 Feb; 38(5):1446-55. PubMed ID: 9931009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benzylisoquinoline compounds inhibit the ability of calmodulin to activate cyclic nucleotide phosphodiesterase.
    Hu ZY; Chen SL; Hao ZG; Huang WL; Peng SX
    Cell Signal; 1989; 1(2):181-5. PubMed ID: 2561985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium-induced quenching of intrinsic fluorescence in brain myosin V is linked to dissociation of calmodulin light chains.
    Cameron LC; Carvalho RN; Araujo JR; Santos AC; Tauhata SB; Larson RE; Sorenson MM
    Arch Biochem Biophys; 1998 Jul; 355(1):35-42. PubMed ID: 9647664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interdomain cooperativity of calmodulin bound to melittin preferentially increases calcium affinity of sites I and II.
    Newman RA; Van Scyoc WS; Sorensen BR; Jaren OR; Shea MA
    Proteins; 2008 Jun; 71(4):1792-812. PubMed ID: 18175310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissimilar mechanisms of action of anticalmodulin drugs: quantitative analysis.
    Orosz F; Telegdi M; Liliom K; Solti M; Korbonits D; Ovádi J
    Mol Pharmacol; 1990 Dec; 38(6):910-6. PubMed ID: 2147457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new potent calmodulin antagonist with arylalkylamine structure: crystallographic, spectroscopic and functional studies.
    Harmat V; Böcskei Z; Náray-Szabó G; Bata I; Csutor AS; Hermecz I; Arányi P; Szabó B; Liliom K; Vértessy BG; Ovádi J
    J Mol Biol; 2000 Mar; 297(3):747-55. PubMed ID: 10731425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calmodulin, activated cyclic nucleotide phosphodiesterase, microtubules, and vinca alkaloids.
    Watanabe K; West WL
    Fed Proc; 1982 May; 41(7):2292-9. PubMed ID: 6122611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calmodulin antagonists enhance calcium binding to calmodulin.
    Inagaki M; Tanaka T; Hidaka H
    Pharmacology; 1983; 27(3):125-9. PubMed ID: 6622516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of pH on Ca-binding properties of calmodulin and on its interaction with Ca-dependent phosphodiesterase of cyclic nucleotides].
    Tkachuk VA; Men'shikov MIu
    Biokhimiia; 1981 Jun; 46(6):963-73. PubMed ID: 6266519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ca2+ binding sites in calmodulin and troponin C alter interhelical angle movements.
    Goto K; Toyama A; Takeuchi H; Takayama K; Saito T; Iwamoto M; Yeh JZ; Narahashi T
    FEBS Lett; 2004 Mar; 561(1-3):51-7. PubMed ID: 15013750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.